Abstract
Background
Sporothrix schenckii strains are the aetiological agents of sporotrichosis, which is endemic in China. The most common clinical manifestation of sporotrichosis is cutaneous and subcutaneous nodular lesions with lymphangitis involvement. Currently, antifungal therapy is commonly used to treat sporotrichosis, however, drug resistance and complications are the major concerns, especially in patients who have asymptomatic liver injury or existing liver disorders, children, and pregnant women.
Objectives
To assess the In vitro and in vivo antifungal efficacy of photodynamic therapy (PDT) using photosensitizer methylene blue against Sporothrix strains isolated from patients.
Materials and Methods
A light-emitting diode (LED) lamp was used as the light source with a wavelength of 640 ± 10 nm. For the In vitro study, the presence of five Sporothrix strains was assayed following LED irradiation with and without photosensitizer(L + M +,L + M-), with photosensitizer alone (L-M +), or no exposure to LED light or photosensitizer (L-M-). For the in vivo study, mice were infected with the fungi and then treated with sodium chloride (control group), antifungal itraconazole alone (itraconazole group), and a combination of antifungal itraconazole and PDT (itraconazole +PDT group), or PDT alone (PDT group).
Results
The results showed that, In vitro, PDT (L + M + ) effectively inhibited fungal growth at an energy density of 40 J/cm2. in vivo, itraconazole +PDT effectively inhibited growth of the fungus with the highest level of efficacy.
Conclusion
PDT with methylene blue is an effective adjuvant therapy for resistant infections of Sporothrix.
Similar content being viewed by others
References
Yu X, Wan Z, Zhang Z, et al. Phenotypic and molecular identification of Sporothrix isolates of clinical origin in Northeast China. Mycopathologia 2013; 176:67–74.
Hu QB, He Y, Zhou X. Construction and analysis of the cDNA subtraction library of yeast and mycelial phases of Sporothrix globosa isolated in China: identification of differentially expressed genes. J Zhejiang Univ Sci B 2015; 16:991–7.
Barros MB, de Almeida Paes R, Schubach AO. Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev 2011; 24:633–54.
Tuccori M, Bresci F, Guidi B, et al. Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis. Ann Pharmacother 2008; 42:1112–7.
Kharkwal GB, Sharma SK, Huang YY, et al. Photodynamic therapy for infections: clinical applications. Lasers Surg Med 2011; 43:755–67.
Černáková L, Chupáčová J, Židlíková K, et al. Effectiveness of the photoactive dye methylene blue versus caspofungin on the Candida parapsilosis biofilm in vitro and ex vivo. Photochem Photobiol 2015; 91:1181–90.
Coulibaly B, Pritsch M, Bountogo M, et al. Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso. J Infect Dis 2015; 211:689–97.
Dai T, Bil de Arce VJ, Tegos GP, et al. Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Antimicrob Agents Chemother 2011; 55:5710–7.
Lyon JP, Pedroso e Silva Azevedo Cde M, Moreira LM, et al. Photodynamic antifungal therapy against chromoblastomycosis. Mycopathologia 2011; 172:293–7.
Nunes Mario DA, Denardi LB, Brayer Pereira DI, et al. In vitro photodynamic inactivation of Sporothrix schenckii complex species. Med Mycol 2014; 52:770–3.
Lyon JP, Moreira LM, de Carvalho VS, dos Santos FV, et al. In vitro photodynamic therapy against Foncecaea pedrosoi and Cladophialophora carrionii. Mycoses 2013; 56:157–61.
Criseo G, Romeo O. Ribosomal DNA sequencing and phy-logenetic analysis of environmental Sporothrix schenckii strains: comparison with clinical isolates. Mycopathologia 2010; 169:351–8.
Poirier JM, Cheymol G. Optimisation of itraconazole therapy using target drug concentrations. Clin Pharmacokinet 1998; 35:461–73.
Gilaberte Y, Aspiroz C, Alejandre MC, et al. Cutaneous sporotri-chosis treated with photodynamic therapy: an in vitro and in vivo study. Photomed Laser Surg 2014; 32:54–7.
Machado-de-Sena RM, Corrêa L, Kato IT, et al. Photodynamic therapy has antifungal effect and reduces inflammatory signals in Candida albicans-induced murine vaginitis. Photodiagnosis Photodyn Ther 2014; 11:275–82.
Hamblin MR, O’ Donnell DA, Murthy N, et al. Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J Antimicrob Chemother 2002; 49:941–51.
Dai T, Fuchs BB, Coleman JJ, et al. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol 2012; 3:120.
Castro RA, Kubitschek-Barreira PH, Teixeira PA, et al. Differences in cell morphometry, cell wall topography and gp70 expression correlate with the virulence of Sporothrix brasiliensis clinical isolates. PLoS One 2013;8:e75656.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Li, J., Zhu, M., An, L. et al. Fungicidal efficacy of photodynamic therapy using methylene blue against Sporothrix globosa in vivo and in vivo. Eur J Dermatol 29, 160–166 (2019). https://doi.org/10.1684/ejd.2019.3527
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2019.3527